Bonaccord Capital Partners made a passive minority investment in $5.6 billion healthcare-focused private equity firm Revelstoke Capital Partners, the firms said in a joint news release.
Bonaccord's investment provides Revelstoke with capital to pursue strategic investments and growth initiatives, the news release said. There will be no change to Revelstoke's investment process, day-to-day management or firm operations.
Bonaccord is a private equity firm that acquires non-controlling equity interests in other private equity money managers.
Executives Bonaccord could not be immediately reached seeking further details about the transaction. A Revelstoke spokesperson could not immediately respond to questions.